Watch CBS News

FDA approves new weight loss drug Zepbound

The Food and Drug Administration has approved the diabetes drug Mounjaro, which will be marketed as a weight loss drug under the name Zepbound.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.